1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline and Brain Disorders

1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline has been researched along with Brain Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Katsuta, K; Nakanishi, H; Shirakawa, K; Takagi, K; Tamura, A; Yoshida, K	1

Other Studies

1 other study(ies) available for 1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline and Brain Disorders

Article	Year
The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1995, Volume: 15, Issue:2 Topics: Animals; Brain Diseases; Brain Ischemia; Dizocilpine Maleate; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tetrahydroisoquinolines	1995

Article

Year

The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1995, Volume: 15, Issue:2

Topics: Animals; Brain Diseases; Brain Ischemia; Dizocilpine Maleate; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tetrahydroisoquinolines

1995